secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGILENT TECHNOLOGIES, INC. (A)
CIK:        0001090872
Form:       8-K
Filed at:   2021-11-19T23:59:59+00:00
Accession:  0001564590-21-057679
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Agilent expands board to 12, appoints Dr. Otis Brawley, oncology expert
-----------------------------------------------------------------------

- Board expanded from 11 to 12 with appointment of Dr. Otis W. Brawley, effective Nov. 17, 2021.
- Brawley will serve on Compensation and Nominating/Corporate Governance Committees.
- He is Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University.
- Also serves on boards of Incyte Corp., Lyell Immunopharma, and PDS Biotechnology.
- Receives standard non-employee director compensation, pro-rated for remainder of 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1090872/000156459021057679/0001564590-21-057679-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1090872/000156459021057679/a-8k_20211117.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-057679

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer